QQQ   304.36 (+0.25%)
AAPL   152.63 (+0.59%)
MSFT   262.97 (+2.41%)
META   188.01 (+1.05%)
GOOGL   104.81 (+1.86%)
AMZN   99.47 (-2.65%)
TSLA   192.69 (-1.06%)
NVDA   215.38 (+2.13%)
NIO   10.65 (-2.56%)
BABA   104.12 (-1.26%)
AMD   83.31 (-0.44%)
T   19.24 (-1.74%)
F   13.24 (+0.76%)
MU   60.48 (+0.83%)
CGC   2.76 (-6.44%)
GE   80.88 (-1.79%)
DIS   110.01 (+0.13%)
AMC   6.30 (-7.35%)
PFE   43.32 (-1.01%)
PYPL   81.61 (-0.87%)
NFLX   357.80 (-1.02%)
QQQ   304.36 (+0.25%)
AAPL   152.63 (+0.59%)
MSFT   262.97 (+2.41%)
META   188.01 (+1.05%)
GOOGL   104.81 (+1.86%)
AMZN   99.47 (-2.65%)
TSLA   192.69 (-1.06%)
NVDA   215.38 (+2.13%)
NIO   10.65 (-2.56%)
BABA   104.12 (-1.26%)
AMD   83.31 (-0.44%)
T   19.24 (-1.74%)
F   13.24 (+0.76%)
MU   60.48 (+0.83%)
CGC   2.76 (-6.44%)
GE   80.88 (-1.79%)
DIS   110.01 (+0.13%)
AMC   6.30 (-7.35%)
PFE   43.32 (-1.01%)
PYPL   81.61 (-0.87%)
NFLX   357.80 (-1.02%)
QQQ   304.36 (+0.25%)
AAPL   152.63 (+0.59%)
MSFT   262.97 (+2.41%)
META   188.01 (+1.05%)
GOOGL   104.81 (+1.86%)
AMZN   99.47 (-2.65%)
TSLA   192.69 (-1.06%)
NVDA   215.38 (+2.13%)
NIO   10.65 (-2.56%)
BABA   104.12 (-1.26%)
AMD   83.31 (-0.44%)
T   19.24 (-1.74%)
F   13.24 (+0.76%)
MU   60.48 (+0.83%)
CGC   2.76 (-6.44%)
GE   80.88 (-1.79%)
DIS   110.01 (+0.13%)
AMC   6.30 (-7.35%)
PFE   43.32 (-1.01%)
PYPL   81.61 (-0.87%)
NFLX   357.80 (-1.02%)
QQQ   304.36 (+0.25%)
AAPL   152.63 (+0.59%)
MSFT   262.97 (+2.41%)
META   188.01 (+1.05%)
GOOGL   104.81 (+1.86%)
AMZN   99.47 (-2.65%)
TSLA   192.69 (-1.06%)
NVDA   215.38 (+2.13%)
NIO   10.65 (-2.56%)
BABA   104.12 (-1.26%)
AMD   83.31 (-0.44%)
T   19.24 (-1.74%)
F   13.24 (+0.76%)
MU   60.48 (+0.83%)
CGC   2.76 (-6.44%)
GE   80.88 (-1.79%)
DIS   110.01 (+0.13%)
AMC   6.30 (-7.35%)
PFE   43.32 (-1.01%)
PYPL   81.61 (-0.87%)
NFLX   357.80 (-1.02%)
NASDAQ:BIB

ProShares Ultra Nasdaq Biotechnology - BIB Stock Forecast, Price & News

$59.00
-1.21 (-2.01%)
(As of 02/7/2023 12:40 PM ET)
Add
Today's Range
$58.85
▼
$60.29
50-Day Range
$55.27
▼
$64.05
52-Week Range
$38.42
▼
$67.31
Volume
12,863 shs
Average Volume
33,283 shs
Market Capitalization
$112.10 million
P/E Ratio
N/A
Dividend Yield
0.03%
Price Target
N/A
Receive BIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Receive BIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares Ultra Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIB
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave
Webwww.proshares.com
Phone+1-240-4976400

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$193.76 million
Average Daily Volume$162,193.00
Discount/Premium-0.09%

ETF Expenses

Management Fee0.75%
Other Expenses0.29%
Total Expenses1.04%
Fee Waiver-0.09%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of BIB

Currency Exposure of BIB

Sector Exposure of BIB

Industry Exposure of BIB














BIB Stock - Frequently Asked Questions

How have BIB shares performed in 2023?

ProShares Ultra Nasdaq Biotechnology's stock was trading at $57.70 on January 1st, 2023. Since then, BIB shares have increased by 4.4% and is now trading at $60.21.
View the best growth stocks for 2023 here.

How often does ProShares Ultra Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology announced a quarterly dividend on Wednesday, December 21st. Stockholders of record on Friday, December 23rd will be paid a dividend of $0.02 per share on Friday, December 30th. This represents a $0.08 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date of this dividend is Thursday, December 22nd.
Read our dividend analysis for BIB.

Is ProShares Ultra Nasdaq Biotechnology a good dividend stock?

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) pays an annual dividend of $0.02 per share and currently has a dividend yield of 0.03%.
Read our dividend analysis for BIB.

What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include Walt Disney (DIS), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Starbucks (SBUX), Advanced Micro Devices (amd), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Visa (V).

What is ProShares Ultra Nasdaq Biotechnology's stock symbol?

ProShares Ultra Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIB."

Who are ProShares Ultra Nasdaq Biotechnology's major shareholders?

ProShares Ultra Nasdaq Biotechnology's stock is owned by a variety of retail and institutional investors. Top institutional investors include Toth Financial Advisory Corp (0.97%) and Private Advisor Group LLC (0.23%).

How do I buy shares of ProShares Ultra Nasdaq Biotechnology?

Shares of BIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

One share of BIB stock can currently be purchased for approximately $60.21.

How much money does ProShares Ultra Nasdaq Biotechnology make?

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) has a market capitalization of $114.40 million.

How can I contact ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States. The official website for the company is www.proshares.com. The exchange traded fund can be reached via phone at +1-240-4976400.

This page (NASDAQ:BIB) was last updated on 2/7/2023 by MarketBeat.com Staff